| Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma S Zweegman, B van der Holt, UH Mellqvist, M Salomo, GMJ Bos, ... Blood, The Journal of the American Society of Hematology 127 (9), 1109-1116, 2016 | 111 | 2016 |
| Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumours ML Wumkes, AMT Van Der Velden, M Los, MBL Leys, A Beeker, ... Vaccine 31 (52), 6177-6184, 2013 | 50 | 2013 |
| Ixazomib-thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for … S Zweegman, CAM Stege, E Haukas, FH Schjesvold, MD Levin, A Waage, ... haematologica 105 (12), 2879, 2020 | 29 | 2020 |
| Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until … LK Nielsen, C Stege, B Lissenberg-Witte, B Van Der Holt, UH Mellqvist, ... haematologica 105 (6), 1650, 2020 | 23 | 2020 |
| Randomized phase III trial in non-transplant eligible patients with newly diagnosed symptomatic multiple myeloma comparing melphalan-prednisone-thalidomide followed by … S Zweegman, B van der Holt, UH Mellqvist, M Salomo, GMJ Bos, ... Blood 124 (21), 179, 2014 | 13 | 2014 |
| Fatal acute hemolytic transfusion reaction due to anti-Wra T Bahri, K De Bruyn, R Leys, F Weerkamp Transfusion Medicine and Hemotherapy 45 (6), 438-441, 2018 | 10 | 2018 |
| Lenalidomide plus melphalan and prednisone, followed by lenalidomide maintenance versus thalidomide plus melphalan and prednisone, followed by thalidomide maintenance; results … S Zweegman, B Van Der Holt, UH Mellqvist, M Salomo, GM Bos, ... Blood 127 (9), 1109-1116, 2016 | 6 | 2016 |
| Phagocytic plasma cells in a patient with smoldering myeloma T Sayar Bahri, F Weerkamp, MBL Leys International journal of hematology 97, 547-548, 2013 | 3 | 2013 |
| Quality of life with melphalan/prednisone plus either thalidomide (MPT-T) or lenalidomide (MPR-R) in non-transplant eligible newly diagnosed multiple myeloma; Results of the … C Stege, B Witte, B Van Der Holt, UH Mellqvist, M Salomo, G Bos, ... Haematologica 102, 190, 2017 | 2 | 2017 |
| P-116 The simplified frailty index (S-FI) identifies a less vulnerable population of frail patients than patients who are defined frail using the International Myeloma working … K Groen, F Smits, K Nasserinejad, MD Levin, J Regelink, GJ Timmers, ... Clinical Lymphoma Myeloma and Leukemia 23, S99, 2023 | | 2023 |
| Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results … K Groen, FH Schjesvold, B Van Der Holt, MD Levin, MR Seefat, ... HemaSphere 7 (9), e940, 2023 | | 2023 |
| P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF … K Groen, C Stege, K Nasserinejad, K de Heer, R van Kampen, R Leys, ... HemaSphere 7 (S2), 16-17, 2023 | | 2023 |
| Meetings and Conferences T Bahri, K de Bruyn, R Leys, F Weerkamp, B Mayer, L Hinkson, W Henrich, ... Transfusion Medicine and Hemotherapy 45 (6), 451-452, 2018 | | 2018 |
| Society Bulletins T Bahri, K de Bruyn, R Leys, F Weerkamp, B Mayer, L Hinkson, W Henrich, ... Transfusion Medicine and Hemotherapy 45 (6), 443-444, 2018 | | 2018 |
| MURANO-studie: venetoclax voor patiënten met recidief of refractaire CLL AP Kater, MD Levin, R Kersting, MED Chamuleau, PJ Lugtenburg, ... Nederlands Tijdschrift voor Hematologie 12 (3), 100-103, 2015 | | 2015 |
| Oncological Case Management and Care for Concerns Regarding Meaning-A Case Study A Visser, H Wolterink, R Leys PSYCHO-ONCOLOGY 22, 179-180, 2013 | | 2013 |
| RESULTS OF THE DUTCH COMMUNITY BASED TRIAL" VALEO" WITH BORTEZOMIB TREATMENT IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS H Lokhorst, P Wijermans, H Berenschot, R Leys, R Raymakers, ... HAEMATOLOGICA 98, 333-334, 2013 | | 2013 |
